SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics is a major talking point following a proposed business combination with Applied Digital's AI cloud division, ChronoScale, which aims to create an accelerated compute platform. The community is buzzing about this strategic pivot, with strong sentiment around its NVIDIA program acceptance and newly reduced share float amplifying expectations for significant future growth in the artificial intelligence space. Many believe the company is currently undervalued and poised for a substantial rally.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending lower amid widespread bearish sentiment, with investors expressing frustration over recent price declines, year-end tax-loss harvesting, and management's communication approach. Despite this, a committed segment of the community remains bullish, pointing to the acquisition of Homebuyer.com, new CEO Kaz Nejatian's vision for AI integration and 2026 profitability, and anticipating a significant rebound.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

Mannatech Inc. ($MTEX) is experiencing heightened investor interest driven by its extremely low public float, leading to significant community speculation about a potential short squeeze and a parabolic breakout. While a strong bullish contingent anticipates substantial gains, others caution against a possible pump-and-dump given the rapid price action without immediate news. This discussion reflects a broader trend of retail traders targeting thinly traded micro-cap stocks for high-volatility, momentum-driven rallies.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust is highly trending following recent volatility attributed to increased margin requirements on precious metals, leading to forced liquidations and extensive profit-taking. The community is sharply divided, with bulls viewing the pullback as a buying opportunity driven by persistent industrial demand and upcoming export restrictions, while bears anticipate further correction after its rapid ascent.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is a focal point of market discussion amidst the impending deadline for its unsupervised robotaxi service and eagerly awaited delivery figures. Community sentiment is sharply split between those anticipating a major leap in AI and autonomous driving capabilities, and skeptics pointing to a high valuation, increasing competition, and slowing EV sales.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending due to promising preliminary data from its FLAMINGO-01 breast cancer trial, which reported an 80% recurrence rate reduction, coupled with extended insider share lock-ups until 2026. The community is buzzing about the potential for a significant short squeeze, fueled by extremely high cost-to-borrow rates and the firm's long-term commitment to shareholder value without immediate dilution.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem is a key topic as it discontinues the RAMP 203 lung cancer trial to pivot resources toward the highly promising KRAS G12D inhibitor, VS-7375, following recent management changes aimed at accelerating growth. This move has polarized the community, with many seeing it as a strategic financial decision to focus on the most impactful pipeline asset, while others voice frustration over the resulting stock decline and concerns about market manipulation.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is experiencing significant discussion following recent positive Phase 3 data for relacorilant in platinum-resistant ovarian cancer, which showcased strong efficacy and a comparable safety profile, driving expectations for an upcoming regulatory filing. Community sentiment is highly optimistic about the drug's multi-billion dollar revenue potential and the possibility of a substantial short squeeze, though some anticipate near-term price consolidation after a rapid appreciation. Investors are also closely monitoring upcoming regulatory decisions for relacorilant in Cushing's syndrome and analyzing promising, yet mixed, survival data from its ALS program.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyx (RARE) is trending due to the unexpected failure of its late-stage brittle-bone disease drug, setrusumab, to meet its primary efficacy endpoint in clinical trials, triggering a significant sell-off. This setback has sparked community discussion about the company's immediate outlook and broader biotech sector risks. However, many investors perceive the sharp decline as an overreaction, citing Ultragenyx's portfolio of approved therapies and other pipeline catalysts as a basis for potential recovery.

FONAR Corp. engages in the design, manufacture, sale, and servicing of magnetic resonance imaging scanners. It operates through Manufacturing and Servicing of Medical Equipment, and Management of Diagnostic Imaging Center segments. The Manufacturing and Servicing of Medical Equipment segment promotes its product, Fonar Upright MRI. The Management of Diagnostic Imaging Center segment offers management, administrative, billing and collection services, office space, equipment, repair, maintenance service and clerical, and non-medical personnel to medical providers through its subsidiary, Health Management Corp. of America. The company was founded by Raymond V. Damadian on July 17, 1978 and is headquartered in Melville, NY.

Fonar Corp.

Fonar (FONR) is trending as the company announced a definitive agreement to be taken private by a group led by its CEO at $19.00 per share. This proposed acquisition price has sparked considerable debate among the community, with many shareholders expressing strong frustration, labeling the deal a "robbery" given the company's debt-free balance sheet, significant cash, and a reported book value substantially exceeding the offer. Investors are actively discussing the fairness of the transaction, especially considering the CEO's controlling stake and the company's profitable operations within the healthcare imaging sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tutor Perini Wins $53 Million Rail Expansion Order In Honolulu

Tutor Perini (NYSE: TPC) awarded $53 million design change order for Honolulu rail project, potential upside tied to funding.read more...

Here is What to Know Beyond Why Tutor Perini Corporation (TPC) is a Trending Stock

Tutor Perini (TPC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Tutor Perini Awarded $53 Million Design Change Order for an Extension to the City Center Guideway and Stations Project in Honolulu

Tutor Perini Corporation (NYSE: TPC) (the Company), a leading civil, building and specialty construction company, announced today that it has been awarded a change order valued at approximately $53...

Pacer Advisors Inc. Sells 52,444 Shares of Tutor Perini Corporation $TPC

Pacer Advisors Inc. cut its position in shares of Tutor Perini Corporation (NYSE:TPC - Free Report) by 11.6% in the third quarter, according to the company in its most recent filing with the...

Tutor Perini (NYSE:TPC) Stock Passes Above 200-Day Moving Average - Time to Sell?

Tutor Perini (NYSE:TPC) Stock Price Crosses Above 200 Day Moving Average - Should You Sell...

Tutor Perini Wins $155M Arts Center Project, Backlog Grows Stronger

TPC adds about $155M to the backlog with a City College of San Francisco arts center win, lifting visibility as record backlog and demand drive growth.

Is Tutor Perini (TPC) Outperforming Other Construction Stocks This Year?

Here is how Tutor Perini (TPC) and Installed Building Products (IBP) have performed compared to their sector so far this year.

5 Construction Stocks Wall Street Analysts Think Will Rally in 2026

Wall Street analysts are backing DY, STRL, FIX, TPC and WMS as top construction picks poised to rally into 2026.

Rudolph and Sletten Awarded $155 Million Diego Rivera Performing Arts Center Project

Tutor Perini Corporation (NYSE: TPC) (the Company), a leading civil, building and specialty construction company, announced today that its subsidiary, Rudolph and Sletten, has been awarded a contract...

Is Trending Stock Tutor Perini Corporation (TPC) a Buy Now?

Zacks.com users have recently been watching Tutor Perini (TPC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Tutor Perini Corp. engages in the provision of construction services. It operates through the following business segments: Civil, Building, and Specialty Contractors. The Civil segment specializes in public works construction and the replacement and reconstruction of infrastructure across the major geographic regions of the United States. The Building segment offers services to a number of specialized building markets for private and public works customers, including hospitality and gaming, transportation, health care, commercial offices, government facilities, sports and entertainment, education, correctional facilities, biotech, pharmaceutical, industrial, and high-tech. The Specialty Contractors segment covers electrical, mechanical, plumbing, HVAC, fire protection systems and pneumatically placed concrete for a full range of civil and building construction projects in the industrial, commercial, hospitality and gaming, and mass-transit end markets. The company was founded by Bonfiglio Perini in 1918 and is headquartered in Sylmar, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.58	--	--	N/A
Q3 '25	$0.46	$0.07	-84.72%	MISSED
Q2 '25	$0.34	$0.38	12.40%	BEAT
Q1 '25	$0.09	$0.53	489.90%	BEAT
Q4 '24	$0.10	-$1.51	-1653.08%	MISSED

TPC
Tutor Perini Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest TPC News

TPCTutor Perini Corp